How to Validate Predictive Immunohistochemistry Testing in Pathology? A Practical Approach Exploiting the Heterogeneity of Programmed Death Ligand-1 Present in Non-Small Cell Lung Cancer
- PMID: 30307747
- DOI: 10.5858/arpa.2018-0410-ED
How to Validate Predictive Immunohistochemistry Testing in Pathology? A Practical Approach Exploiting the Heterogeneity of Programmed Death Ligand-1 Present in Non-Small Cell Lung Cancer
Comment in
-
How to Validate Predictive Immunohistochemistry Testing in Pathology?Arch Pathol Lab Med. 2019 Aug;143(8):907. doi: 10.5858/arpa.2019-0056-LE. Arch Pathol Lab Med. 2019. PMID: 31339752 No abstract available.
-
In Reply.Arch Pathol Lab Med. 2019 Aug;143(8):909-910. doi: 10.5858/arpa.2019-0198-LE. Arch Pathol Lab Med. 2019. PMID: 31339755 No abstract available.
-
Predictive Markers Require Thorough Analytic Validation.Arch Pathol Lab Med. 2019 Aug;143(8):907-909. doi: 10.5858/arpa.2019-0112-LE. Arch Pathol Lab Med. 2019. PMID: 31339757 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials